Celularity Inc. Class A (CELU) Financials

$0.80

$-0.05 (-5.79%)

As on 30-Oct-2026 16:00EST

Market cap

$26 Mln

Revenue (TTM)

$17 Mln

P/E Ratio

--

P/B Ratio

9.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	17.49	26.55	54.22	22.77	17.98	21.34
Cost of Revenue	18.55	20.07	14.99	16.02	19.67	9.65
Gross Profit	-1.06	6.48	39.23	6.76	-1.69	11.68
Operating Expenses	64.80	67.78	77.59	99.25	23.91	120.74
Operating Profit (EBIT)	-58.49	-61.31	-38.36	-76.48	-25.60	-109.06
Other Income	--	--	--	--	--	--
Profit before Tax	-47.14	-91.71	-57.89	-196.29	14.21	-100.10
Provision for Tax	0.00	0.00	0.01	--	0.01	0.02
Profit after Tax (Net Income)	-47.14	-91.72	-57.89	-196.30	14.19	-100.12
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	14.19	-100.12

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-35.53	-38.06	8.84	40.96	198.90	99.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	71.96	64.63	70.17	35.63	140.08	288.49
Current Liabilities	59.74	80.76	53.68	67.30	62.09	26.23
Total Liabilities	155.91	107.33	132.68	143.89	401.07	414.13

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	89.72	95.01	112.12	124.10	367.56	376.89
Current Assets	6.45	12.32	20.56	19.79	33.50	37.24
Total Assets	102.62	107.33	132.68	143.89	401.07	414.13
Total Debt*	36.02	40.90	68.84	--	65.59	31.14
Net Current Assets	--	-68.44	-33.12	-47.51	-28.59	32.88

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-13.25	-6.40	-38.69	-137.88	-110.10
Cash Flow from Investing Activities	--	--	0.51	--	-5.24	-5.90
Cash from Financing Activities	--	18.65	6.70	24.09	119.84	98.56
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.74	-3.18	-2.57	-10.42	0.95	-8.07
Cash EPS ($)	-1.69	-2.93	-2.22	-9.93	1.59	-7.36
Adjusted Book Value ($)	-1.21	--	0.39	2.18	13.36	8.01
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.46	-0.28	-2.05	-9.26	-8.87
Free Cash Flow per Share ($)	--	-0.46	-0.29	-2.27	-9.61	-9.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-227.83	-97.60	-128.53	7.19	-111.30
ROE (%)	--	627.65	-232.51	-163.67	9.51	-169.50
ROA (%)	-33.42	-76.43	-41.86	-72.04	3.48	-23.69
EBIT Margin (%)	-256.29	-320.00	-95.22	-848.75	-824.85	-454.31
Net Margin (%)	-269.61	-345.45	-106.77	-862.04	78.95	-469.27
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-63.02	-0.51	1.38	0.27	-0.16	0.49
EBIT Growth (%)	31.20	-64.56	73.29	-30.35	-52.97	53.97
Net Profit Growth (%)	36.45	-58.43	70.51	-1,483.14	114.18	51.92
EPS Growth (%)	43.41	-0.24	0.75	-11.94	1.12	0.93
Book Value Growth (%)	-58.77	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.35	-0.81	-0.02	1.35	-0.63
Price / Book Value	9.89	-0.84	5.31	0.11	0.10	0.64
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-36.78	-0.86	-2.63	-0.02	-0.51	-0.65
Close Price ($)	1.35	1.11	2.08	2.47	12.90	51.20
High Price ($)	2.55	4.35	7.97	13.90	131.86	134.00
Low Price ($)	0.56	1.00	1.30	1.59	10.49	43.90
Market Cap ($ Cr)	25.96	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.07	7.79	--	0.33	0.31
Short term debt to equity ratio	-0.25	-0.37	0.72	--	0.19	0.03
Current Ratio	0.11	0.15	0.38	0.29	0.54	1.42
Quick Ratio	0.10	0.15	0.28	0.21	0.45	1.06
Interest Coverage	-19.29	-12.58	-8.24	-64.10	-46.76	-30.57

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	26.77	17.53	25.00	44.12	38.75	24.53
Asset Turnover	0.12	0.22	0.39	0.08	0.04	0.05
Receivable days	--	125.26	79.50	136.44	123.94	100.86
Inventory Days	--	54.40	136.00	126.12	137.97	253.50
Payable days	--	452.31	456.17	227.53	140.48	278.24
Cash Conversion Cycle	--	-272.65	-240.67	35.03	121.43	76.12

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.